We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,988
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKG icon
4001
CALL
Packaging Corp of America
PKG
$22.6B
$3.86M ﹤0.01%
28,000
-19,400
-41% -$2.44M
DAR icon
4002
PUT
Darling Ingredients
DAR
$10.6B
$3.86M ﹤0.01%
66,900
+13,900
+26% +$664K
LSPD icon
4003
CALL
Lightspeed Commerce
LSPD
$1.35B
$3.86M ﹤0.01%
+54,800
New +$2.53M
ROBT icon
4004
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$784M
$3.86M ﹤0.01%
76,867
+67,214
+696% +$2.98M
IBN icon
4005
CALL
ICICI Bank
IBN
$106B
$3.85M ﹤0.01%
259,300
+84,300
+48% +$1.06M
CMPS
4006
Compass Pathways
CMPS
$1.88B
$3.85M ﹤0.01%
80,871
-205,283
-72% -$8.75M
OSUR icon
4007
PUT
OraSure Technologies
OSUR
$263M
$3.85M ﹤0.01%
363,800
+305,200
+521% +$4M
LPRO
4008
DELISTED
Open Lending Corp
LPRO
$3.85M ﹤0.01%
+110,012
New +$3.2M
SHYD icon
4009
VanEck Short High Yield Muni ETF
SHYD
$457M
$3.85M ﹤0.01%
+155,084
New +$3.79M
VERI icon
4010
Veritone
VERI
$107M
$3.85M ﹤0.01%
+135,153
New +$2.34M
RETA
4011
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.85M ﹤0.01%
31,100
-18,800
-38% -$2.47M
GDRX icon
4012
CALL
GoodRx Holdings
GDRX
$1.26B
$3.84M ﹤0.01%
+95,300
New +$4.38M
IPO icon
4013
CALL
Renaissance IPO ETF
IPO
$160M
$3.84M ﹤0.01%
+59,600
New +$3.52M
CPRT icon
4014
PUT
Copart
CPRT
$29.6B
$3.84M ﹤0.01%
120,800
-161,200
-57% -$4.7M
VXZ icon
4015
PUT
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.5M
$3.84M ﹤0.01%
31,200
+25,650
+462% +$3.26M
NOV icon
4016
CALL
NOV
NOV
$7.65B
$3.84M ﹤0.01%
279,600
+112,700
+68% +$1.27M
CUK
4017
DELISTED
Carnival PLC
CUK
$3.84M ﹤0.01%
204,752
-219,807
-52% -$3.41M
FMX icon
4018
PUT
Fomento Económico Mexicano
FMX
$40B
$3.83M ﹤0.01%
50,600
+1,600
+3% +$107K
ARNA
4019
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.83M ﹤0.01%
49,900
+30,200
+153% +$2.26M
IDLV icon
4020
Invesco S&P International Developed Low Volatility ETF
IDLV
$346M
$3.83M ﹤0.01%
127,799
+36,326
+40% +$1.06M
DRIP icon
4021
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$102M
$3.83M ﹤0.01%
1,443
+883
+158% +$4.07M
ICPT
4022
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.83M ﹤0.01%
155,000
+36,900
+31% +$1.22M
KBAL
4023
DELISTED
Kimball International
KBAL
$3.83M ﹤0.01%
320,390
+224,820
+235% +$2.56M
IDEV icon
4024
iShares Core MSCI International Developed Markets ETF
IDEV
$32.8B
$3.82M ﹤0.01%
62,044
+23,620
+61% +$1.37M
CHRS icon
4025
Coherus Oncology
CHRS
$184M
$3.82M ﹤0.01%
219,990
-46,276
-17% -$824K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.